American Rebel Holdings shares are trading lower after receiving a Nasdaq delisting notice, adding to uncertainties despite a recent distribution partnership announcement.

AIM ImmunoTech shares are trading higher after the company announced the commencement of its rights offering to raise up to $12 million.

Disc Medicine, Inc. shares are trading lower after Pomerantz Law Firm announced an investigation into claims of securities fraud by the company's officers and/or directors.

Profusa shares are trading lower as the market reacts to its new collaboration with Mayo Clinic to advance clinical applications of oxygen monitoring technologies, despite the lack of immediate financial boost or analyst ratings.

Amwell shares are trading higher after the company reported strong financial results for the fourth quarter and full year 2025, highlighting significant growth and dependable outcomes for millions of patients.

Cooper Standard shares are trading higher after reporting strong fourth-quarter cash flow and continued margin expansion, underscoring the resilience of its financial performance despite industry disruptions.

Cineverse shares are trading higher after the company announced a strategic acquisition of IndiCue, a profitable CTV monetization platform, expected to contribute significantly to revenue and operating leverage.

Bright Horizons Family Solutions shares are trading lower after the company reported a decrease in income from operations for Q4 2025, despite a 9% revenue increase. The decline is attributed to incremental impairment and net lease termination costs.

Instacart shares are trading higher after the company announced its fourth quarter and full year 2025 financial results, demonstrating strong performance and transitioning to an annual shareholder letter format.

Sensient Technologies Corporation shares are trading lower after the company reported mixed financial results for Q4 2025, with decreased operating income and increased costs from its Portfolio Optimization Plan.

Forrester Research shares are trading lower after the company reported a 6% decline in contract value and a substantial goodwill impairment, leading to a net loss in their recent financial results.

Intensity Therapeutics shares are trading lower after the company announced a 1-for-25 reverse stock split to regain compliance with Nasdaq's listing requirements.

Bio-Rad Laboratories shares are trading lower after the company reported financial results for the fourth quarter and full-year 2025 that underwhelmed expectations, driven by geopolitical uncertainties and pressures on academic research funding.

Fortune Brands Innovations shares are trading lower after the announcement of a CEO transition, with Amit Banati set to take over from Nicholas Fink. Additionally, the company's latest financial results showed decreased profitability, prompting management to seek structural improvements in cost efficiency amidst a challenging market environment.

Sensus Healthcare shares are trading lower after the company announced Q4 2025 financial results showing a net loss of $3.2 million compared with a net income of $1.5 million in Q4 2024. The decline was primarily driven by reduced sales to their largest customer and higher servicing costs.

Magna shares are trading higher after the company announced solid fourth-quarter results, with adjusted EBIT increasing by 18% and a positive outlook for 2026, featuring expected sales between $41.9 billion and $43.5 billion.

SPS Commerce shares are trading higher following the appointment of new independent directors to its board and reporting strong financial results with 18% annual revenue growth and increased share repurchase authorization.

Immunic shares are trading higher after the company announced an oversubscribed private placement of up to USD 400 million to support its transition into a commercial-stage company, including funding for key phase 3 trials.

Tri Pointe Homes shares are trading higher after Sumitomo Forestry announced a strategic acquisition with a 29% premium to the closing stock price, valuing the transaction at approximately $4.5 billion.

Nu Skin Enterprises shares are trading lower despite reporting over 50% growth in earnings for 2025. The negative sentiment is attributed to declining revenue and customer numbers, further impacted by foreign currency headwinds and market challenges.